Which conditions contributing to the Charlson score predict survival after radical prostatectomy?

Journal of Urology

Volumn 171, Issue 2 I, 2004, Pages 697-699

  Froehner, Michael ^a   Koch, Rainer ^a   Litz, Rainer ^a   Oehlschlaeger, Sven ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Comorbidity; Prognosis; Prostate; Prostatectomy; Prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHARLSON SCORE; COMORBIDITY; CONGESTIVE HEART FAILURE; DEATH; HAZARD ASSESSMENT; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL HAZARD RATIO; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM;

EID: 0347129587     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000108138.36333.09     Document Type: Article

References (10)

1. Albertsen, P. C., Fryback, D. G., Storer, B. E., Kolon, T. F. and Fine, J.: The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol, 156: 127, 1996
2. Barry, M. J., Albertsen, P. C., Bagshaw, M. A., Blute, M. L., Cox, R., Middleton, R. G. et al: Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer, 91: 2302, 2001
3. Fowler, J. E., Jr., Bigler, S. A., White, P. C. and Duncan, W. L.: Hormone therapy for locally advanced prostate cancer. J Urol, 168: 546, 2002
4. Cooperberg, M. R., Lubeck, D. P., Penson, D. F., Mehta, S. S., Carroll, P. R. and Kane, C. J.: Sociodemographic and clinical risk characteristics of patients with prostate cancer within the Veterans Affairs health care system: data from CAPSURE. J Urol, 170: 905, 2003
5. Fowler, J. E., Jr., Terrell, F. L. and Renfroe, D. L.: Co-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapy. J Urol, 156: 1714, 1996
6. Sweat, S. D., Bergstralh, E. J., Slezak, J., Blute, M. L. and Zincke, H.: Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol, 168: 525, 2002
7. Charlson, M. E., Pompei, P., Ales, K. L. and MacKenzie, C. R.: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis, 40: 373, 1987
8. Froehner, M., Koch, R., Litz, R., Heller, A., Oehlschlaeger, S. and Wirth, M. P.: Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology, 62: 698, 2003
9. Holmberg, L., Bill-Axelson, A., Helgesen, F., Salo, J. O., Folmerz, P., Haggman, M. et al: A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med, 347: 781, 2002
10. Miller, D. C., Taub, D. A., Dunn, R. L., Montie, J. E. and Wei, J. T.: The impact of co-morbid disease on cancer control and survival following radical cystectomy. J Urol, 169: 105, 2003